Výsledky vyhledávání - "Franz, Recker"

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

Autor: Joel R Federer-Gsponer, Christian Wetterauer, Maciej Kwiatkowski, Franz Recker, Robin Mona, Hans Helge Seifert, Lukas Manka, F. Leboutte, Cyrill A. Rentsch, Stephen Wyler, Jan Ebbing

Publikováno v: Urologia Internationalis. 106:83-89

Introduction: Active surveillance (AS) strategies were established to avoid overtreatment of low-risk prostate cancer (PCa) patients. Low tumor volume represents one indication criteria; however, applying this criterion after MRI-targeted prostate bi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20846daddd5e7c38bd5941550c177526
https://doi.org/10.1159/000517300

Zobrazit plný text záznamu

Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?

Autor: Monique J. Roobol, Franz Recker, Teuvo L.J. Tammela, Anssi Auvinen, Sue Moss, Chris H. Bangma, Jonas Hugosson, Maciej Kwiatkowski, Sigrid Carlsson, Marianne Månsson

Publikováno v: Eur Urol
European Urology, 75(6), 1015-1022. Elsevier

Background Differential treatment between trial arms has been suggested to bias prostate cancer (PC) mortality in the European Randomized Study of Screening for Prostate Cancer (ERSPC). Objective To quantify the contribution of treatment differences

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79e44cfc429859c3a5451771e5f74c51
https://doi.org/10.1016/j.eururo.2019.03.010

Zobrazit plný text záznamu

Akademický článek

Prostate cancer screening: and yet it moves!

Autor: Maciej Kwiatkowski, Marco Randazzo, Luis Kluth, Lukas Manka, Andreas Huber, Franz Recker

Publikováno v: Asian Journal of Andrology, Vol 17, Iss 3, Pp 437-438 (2015)

The debate of prostate cancer (PCa) screening has been shaped over decades. There is a plethora of articles in the literature supporting as well as declining prostate-specific antigen (PSA) screening. Does screening decrease PCa mortality? With the l

Externí odkaz: https://doaj.org/article/212269badb9c4b41aa7919c535a597b4

Zobrazit plný text záznamu

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Publikováno v: European Urology, 76(1), 43-51. Elsevier
European Urology
European Urology, Elsevier, 2019, 76 (1), pp.43-51. ⟨10.1016/j.eururo.2019.02.009⟩
Eur Urol
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology

Background: The European Randomized study of Screening for Prostate Cancer (ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening decreases prostate cancer (PCa) mortality. Objective: To determine whether PSA screening dec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db885d09aad8a6ae369f9aaf3aba8f6
https://doi.org/10.1016/j.eururo.2019.02.009

Zobrazit plný text záznamu

Summary statement on screening for prostate cancer in Europe

Autor: Martin Eklund, Harry J. de Koning, Vera Nelen, Markus Graefen, Xavier Castells, Chris H. Bangma, Henrik Grönberg, Josep A. Espinàs, Franz Recker, Eveline A.M. Heijnsdijk, Iris Lansdorp-Vogelaar, Tiago M. de Carvalho, Pieter Vandenbulcke, Josep M. Borràs, Monique J. Roobol, Pim J. van Leeuwen

Publikováno v: International Journal of Cancer. 142:741-746

The European Randomised Study of Screening for Prostate Cancer (ERSPC) showed that Prostate-Specific Antigen (PSA) based screening results in a significant prostate cancer mortality reduction. Although there are concerns on overdiagnosis and overtrea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::21aeb8f933425c5e9221c7148c15ad38
https://doi.org/10.1002/ijc.31102

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání